Cargando…

P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.

Detalles Bibliográficos
Autores principales: Vesole, David H., Berdeja, Jesus, Matous, Jeffrey, Trudel, Suzanne, Schade, Henning, Munster, Pamela, Berkeley, Savannah, Sun, Benjamin, Martin, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431115/
http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93
_version_ 1785091123457294336
author Vesole, David H.
Berdeja, Jesus
Matous, Jeffrey
Trudel, Suzanne
Schade, Henning
Munster, Pamela
Berkeley, Savannah
Sun, Benjamin
Martin, Tom
author_facet Vesole, David H.
Berdeja, Jesus
Matous, Jeffrey
Trudel, Suzanne
Schade, Henning
Munster, Pamela
Berkeley, Savannah
Sun, Benjamin
Martin, Tom
author_sort Vesole, David H.
collection PubMed
description
format Online
Article
Text
id pubmed-10431115
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311152023-08-17 P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. Vesole, David H. Berdeja, Jesus Matous, Jeffrey Trudel, Suzanne Schade, Henning Munster, Pamela Berkeley, Savannah Sun, Benjamin Martin, Tom Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431115/ http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Vesole, David H.
Berdeja, Jesus
Matous, Jeffrey
Trudel, Suzanne
Schade, Henning
Munster, Pamela
Berkeley, Savannah
Sun, Benjamin
Martin, Tom
P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title_full P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title_fullStr P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title_full_unstemmed P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title_short P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
title_sort p902: isatuximab, weekly carfilzomib and dexamethasone as salvage therapy for rrmm; interim results from a phase 2 trial.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431115/
http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93
work_keys_str_mv AT vesoledavidh p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT berdejajesus p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT matousjeffrey p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT trudelsuzanne p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT schadehenning p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT munsterpamela p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT berkeleysavannah p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT sunbenjamin p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial
AT martintom p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial